Cargando…
In Vitro High Throughput Screening, What Next? Lessons from the Screening for Aurora Kinase Inhibitors
Based on in vitro assays, we performed a High Throughput Screening (HTS) to identify kinase inhibitors among 10,000 small chemical compounds. In this didactic paper, we describe step-by-step the approach to validate the hits as well as the major pitfalls encountered in the development of active mole...
Autores principales: | Hoang, Thi-My-Nhung, Vu, Hong-Lien, Le, Ly-Thuy-Tram, Nguyen, Chi-Hung, Molla, Annie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4009756/ https://www.ncbi.nlm.nih.gov/pubmed/24833340 http://dx.doi.org/10.3390/biology3010167 |
Ejemplares similares
-
Basal aurora kinase B activity is sufficient for histone H3 phosphorylation in prophase
por: Le, Ly-Thuy-Tram, et al.
Publicado: (2013) -
Dual roles of oxostephanine as an Aurora kinase inhibitor and angiogenesis suppressor
por: Tran, Thu-Hien Thi, et al.
Publicado: (2022) -
High-throughput kinase inhibitor screening reveals roles for Aurora and Nuak kinases in neurite initiation and dendritic branching
por: Blazejewski, Sara M., et al.
Publicado: (2021) -
Discovery of benzo[e]pyridoindolones as kinase inhibitors that disrupt mitosis exit while erasing AMPK-Thr172 phosphorylation on the spindle
por: Le, Ly-Thuy-Tram, et al.
Publicado: (2015) -
The Discovery of Aurora Kinase Inhibitor by Multi-Docking-Based Virtual Screening
por: Kim, Jun-Tae, et al.
Publicado: (2014)